Winter Charles M. 4
4 · Janux Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Winter Charles M.
Chief Technical Officer
Transactions
- Award
Common Stock
2025-01-02+23,000→ 77,288 total - Award
Stock option (right to buy)
2025-01-02+80,500→ 80,500 totalExercise: $53.24Exp: 2035-01-01→ Common Stock (80,500 underlying)
Footnotes (3)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.
- [F2]Includes 1,297 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on November 15, 2021, 1,644 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023, 2,834 shares acquired under the Plan on May 15, 2024 and 1 share acquired under the Plan on November 15, 2024.
- [F3]25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.